On the evening of May 28, 2026, the event themed Integration & Breakthrough — The Second 2026 Meeting of FNY Strategy Committee and Development Committee was held in Xichang, Sichuan. Geng Funeng, Chairman of Good Doctor Group and Founder of the “Good Doctor” brand, attended the meeting to provide on-site guidance. FNY’s core management team together with key members of the Strategy Committee and Development Committee gathered to review work progress, align strategic thinking, arrange key tasks for the second half of the year, build consensus and gather momentum for the high-quality and sustainable development of FNY.

Prior to the formal meeting, all core members of the two committees took part in an on-site study tour of the enterprise. The group visited the Good Doctor Culture Exhibition Hall and the exhibition hall featuring the “Six Uniqueness and Three Advantages” of American cockroaches. They gained in-depth understanding of the original aspiration of Good Doctor and FNY in cultivating the big health industry, and systematically learned about the core value and modern application achievements of American cockroaches, a distinctive medicinal material.

Afterwards, the delegation visited CanonDa Smart TCM Decoction & Preparation Center. They observed this benchmark intelligent TCM decoction factory in Panxi Region at close range, witnessing the deep integration of traditional Chinese medicine and modern digital intelligent technology. The visit enabled participants to directly experience the full industrial chain layout and solid scientific research strength of Good Doctor Group, further strengthening their confidence to pursue the business and achieve coordinated development.

At the opening of the meeting, Geng Funeng delivered an important speech. He pointed out that the big health industry is an evergreen sunrise sector. Safeguarding public health and disseminating scientific health concepts constitute the enduring core mission of Good Doctor and FNY. This meeting serves not only as a strategic deployment session, but also a communication platform for mutual learning and unity. He encouraged all core members to enhance capabilities through continuous learning, optimize services in dedicated practice, and steadily improve customers’ health and well-being.

Meanwhile, he emphasized the importance of team unity and travel safety. He expected all participants to devote themselves to learning and pragmatic development, and extended best wishes for the smooth running of the Records of Herbal Medicine, A New Beginning for All — FNY 15th Anniversary Carnival & the 2nd Herbal Science and Technology Brand Festival.

Geng Yuechang, Deputy General Manager of Good Doctor Group and Chairman of FNY, shared insights on team building and long-term development. He stressed that team development must adhere to the core principle of prioritizing professionalism and empowering strengths. Teams should proactively break rigid mindsets and traditional development models. Core personnel at all levels must take responsibility, maintain a positive attitude, abandon short-term profit-oriented thinking, focus on the long-term sustainable growth of FNY, consolidate team cohesion, lay a solid foundation for development, and steadily drive the big health business forward.

Li Nan, President of FNY, released the core strategy and work plan for the next phase of 2026. He clarified that 2026 marks a critical year for FNY to achieve integration and breakthrough. Guided by the action guideline of One Core, Two Engines, Three Modernizations, Four Dimensions, Five Comprehensive Initiatives, the company will implement a dual-driven development model featuring in-depth integration of online and offline operations.

Offline efforts will focus on rolling out Good Doctor Guzheng Chinese Medicine Centers and Good Doctor Guzheng New TCM Health Experience Stores to build core physical service venues. Online development will center on the Little Fu Selection e-commerce platform. The online-offline linkage will tackle industry bottlenecks and realize cross-border value symbiosis. In addition, the company will steadily advance global layout in the second half of the year, accelerate expansion into overseas markets, and foster a bidirectional development pattern covering domestic and international markets.

You Yan, Vice President of FNY and General Manager of the Brand Operation Center, elaborated on FNY’s new product R&D roadmap. She stated that drawing on the Group’s profound heritage in traditional Chinese medicine and cutting-edge scientific research capabilities, FNY will continuously upgrade its health product portfolio covering multiple health tracks including constitution conditioning, weight management and sleep care. Multiple core products are undergoing iterative upgrading and launch preparation. Innovative new products developed by top-tier research teams will be unveiled successively. A diversified, high-quality product matrix will consolidate the core competitiveness of the FNY brand.

Hou Xugang, Vice President of FNY and General Manager of the Market Management Center, shared views on standardized market governance and team empowerment. In response to prevailing industry conditions, he announced that the company will vigorously curb improper market behaviors such as undercutting and disordered pricing online. Standardized policies will regulate market order to build a fair and sound market environment and effectively protect the legitimate rights and interests of all partners. Furthermore, the company will launch a series of professional and systematic training programs and industry exchange activities to fully empower core teams, helping key personnel upgrade professional competence, refine market strategies and expand business efficiently.

Toward the end of the meeting, Chairman Geng Funeng presented exclusive premium health gifts to all core members of the Strategy Committee and Development Committee, namely Angong Niuhuang Pills and Haima Duobian Pills. These carefully selected gifts embody the Group’s sincere concern for the physical health of FNY’s core team, as well as good expectations for joint development and new breakthroughs. All participants felt deeply warmed and inspired.

This meeting functions both as a work summary session for identifying gaps and reviewing outcomes, and a strategic mobilization meeting to unite strength and strive for breakthroughs. It lays a solid foundation for FNY’s market expansion, team upgrading and strategy implementation in the second half of 2026. Moving forward, FNY will stay committed to the development path of product innovation, compliant operation, digital empowerment and global layout. Working hand in hand with all core partners, FNY will forge ahead and write a new chapter of high-quality corporate development.